November 18th, 2026Nurses Are Key to Keeping Complex Cancer Care Close to HomeJan Franko, MD, PhD, explains how integrated teams of nurses, nurse practitioners, and navigators help patients get complex cancer care near home.Read more
November 18th, 2026Chris Draft: Nurses Translate a Lung Cancer Diagnosis Into a Game PlanFormer NFL linebacker Chris Draft shares how his late wife's lung cancer launched Team Draft and how nurses help families decode a new diagnosis.Read more
November 17th, 2026Supplement Novilora Launches in US for CIPN SupportThe supplement, sold in Europe as OnLife, was evaluated in the single-arm STEFANO study of 146 patients with paclitaxel- or oxaliplatin-induced CIPN.Read more
November 17th, 2026Giredestrant Approval: What Nurses Need to Know and What Comes NextThe evERA principal investigator explains ESR1 testing, bradycardia and stomatitis prevention, and oral adherence with giredestrant plus everolimus.Read more
November 17th, 2026SONO 2026: Beth Sandy Ties NSCLC Treatment Updates to Nursing Toxicity CareBeth Sandy, MSN, CRNP, FAPO, reviewed ADCs, immunotherapy, and targeted therapy in NSCLC with a focus on what nurses should monitor.Read more
November 17th, 2026FDA Grants Accelerated Approval to Neladalkib in Pretreated ALK+ NSCLCNeladalkib produced response rates of 49% after alectinib and 32% after multiple ALK TKIs plus chemotherapy in the ALKOVE-1 trial.Read more
November 17th, 2026From Oncology Nurse to Care Partner: Lessons From a Couple Facing NMIBCJoAnne Page, RN, a breast cancer survivor, shares what oncology nurses can do for care partners of patients with bladder cancer.Read more
November 16th, 2026FDA Approves Giredestrant Plus Everolimus for ESR1-Mutated Breast CancerGiredestrant (Wilserdly) plus everolimus nearly doubled median PFS vs standard endocrine therapy plus everolimus in ESR1-mutated disease in evERA.Read more